AQP4 and neuromyelitis optica: Following immunization with an mRNA COVID-19 vaccine the patient suffered from a severe disease exacerbation presenting as LETM which led to clinical re-evaluation and ultimately diagnosis of NMO due to detection of AQP4-autoantibodies in both serum and CSF.